Hulin C, Offner F, Moreau P, Roussel M, Belhadj K, Benboubker L, Caillot D, Facon T, Garderet L, Kuhnowski F, Stoppa A-M, Kolb B, Tiab M, Jie K-S, Westerman M, Lambert J, Pei L, Vanquickelberghe V, de Boer C, Vermeulen J, Kampfenkel T, Sonneveld P, van de Donk NW. Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study. haematol [Internet]. 2021Aug.1 [cited 2024Nov.28];106(8):2257-60. Available from: https://haematologica.org/article/view/haematol.2020.261842